Debut Plus

2,059.3

-5.58 -0.27%

17 Jul 2026

NSE Listed

Corona Remedies Limited (CORONA)

Volume: 27,367Avg Vol 1W: 26,777.2Avg Vol 1M: 36,500.152W Range:1,336.62,123.7
Key Ratios
Checked 7h ago
Market Cap₹12,629 Cr
Current Price₹2,059.3
Previous Close₹2,064.88
High / Low (52w)₹2,123.7 / ₹1,336.6
Volume27,367
Avg Vol (1W)26,777.2
Avg Vol (1M)36,500.1
Stock P/E278.66
Book Value₹122.12
Dividend Yield48%
ROE24.79%
ROA15.36%
Revenue (TTM)₹1,414 Cr
Revenue Growth17.9%
Profit Margin13.19%
Total Debt₹16 Cr
Shares Outstanding6 Cr
Face Value₹10
EPS (TTM)₹32.68
P/B16.93
Debt / Equity0.19
50 DMA₹1,853.61
200 DMA₹1,645.86
Day change-0.27%
Price Chart
2,059.3 43.17% · 1Y
206313481.3Cr
2025-12-15
2026-07-16

20-day avg volume: 37K shares

Pros
  • Healthy return on equity of 24.8%.
  • Pays a dividend yield of 48.0%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 279.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹314 Cr₹298 Cr₹294 Cr₹347 Cr₹361 Cr₹342 Cr₹353 Cr
EBITDA₹60 Cr₹60 Cr₹46 Cr₹63 Cr₹72 Cr₹76 Cr₹56 Cr
Net Profit₹43 Cr₹45 Cr₹32 Cr₹46 Cr₹52 Cr₹41 Cr₹45 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹605 Cr₹624 Cr₹891 Cr₹1,021 Cr₹1,202 Cr₹1,414 Cr
EBITDA₹79 Cr₹4 Cr₹115 Cr₹133 Cr₹209 Cr₹266 Cr
Net Profit₹59 Cr₹0 Cr₹85 Cr₹91 Cr₹149 Cr₹185 Cr
EPS106.83-0.0814.5714.824.4330.27
Balance Sheet
MetricMar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹396 Cr₹511 Cr₹595 Cr₹831 Cr₹930 Cr₹1,205 Cr
Total Liabilities₹127 Cr₹190 Cr₹187 Cr₹350 Cr₹324 Cr₹458 Cr
Equity₹269 Cr₹321 Cr₹409 Cr₹480 Cr₹606 Cr₹747 Cr
Total Debt₹18 Cr₹17 Cr
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹99 Cr₹129 Cr₹175 Cr₹234 Cr₹279 Cr
Investing₹-66 Cr₹-50 Cr₹-267 Cr₹-84 Cr₹-256 Cr
Financing₹-30 Cr₹-45 Cr₹99 Cr₹-107 Cr₹25 Cr
Free Cash Flow₹99 Cr₹129 Cr₹175 Cr₹234 Cr₹279 Cr
Shareholding
Promoter 69% Institutions 16.53% Public 14.48%
Efficiency & Working Capital
ROCE27.1%
Interest Coverage35.5
Dividend Payout
Debtor Days38 d
Inventory Days33 d
Payable Days38 d
Cash Conversion Cycle32 d
Working Capital Days70 d
Shareholding Details

As of 2026-06-30

Promoter69%
FII3.6%
DII12.9%
Institutions16.5%
Public14.5%
Promoter Pledge0%
No. of Shareholders20,185
Shareholding Pattern

Quarterly — figures in %. Latest 5 quarters.

PeriodApr 2025Apr 2025Dec 2025Mar 2026Jun 2026
Promoters72.5%72.5%69%69%69%
FIIs0%0%1.8%2.2%3.6%
DIIs27.5%0%6.8%7%12.9%
Public0%27.5%22.4%21.7%14.5%
Promoter Pledge0%0%0%0%0%
No. of Shareholders9931,03519,60920,185
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Ankurbhai K MehtaShareholding of Promoter and Promoter Group22%1.35 Cr
Nirav Kirtikumar MehtaShareholding of Promoter and Promoter Group22%1.35 Cr
Kirtikumar Laxmidas MehtaShareholding of Promoter and Promoter Group20%1.22 Cr
Sepia Investments LimitedPublic Shareholding12.7%77,55,786
Invesco India Smallcap FundPublic Shareholding5.1%30,92,372
Hdfc Trustee Company Limited-hdfc Flexi Cap FundPublic Shareholding4.1%25,06,683
Dipaben Niravkumar MehtaShareholding of Promoter and Promoter Group2%12,22,047
Brinda Ankur MehtaShareholding of Promoter and Promoter Group2%12,22,047
Minaxi Kirtikumar MehtaShareholding of Promoter and Promoter Group1%6,08,567
Hetvi Nirav MehtaShareholding of Promoter and Promoter Group0%0
Vanshaj Niravkumar MehtaShareholding of Promoter and Promoter Group0%0
Jitendrakumar Champaklal VoraShareholding of Promoter and Promoter Group0%0
Chandrika Jitendrakumar VoraShareholding of Promoter and Promoter Group0%0
Nehal Devang VoraShareholding of Promoter and Promoter Group0%0
Heti Darshan KothariShareholding of Promoter and Promoter Group0%0
Vishwa Ankur MehtaShareholding of Promoter and Promoter Group0%0
Jainam Ankur MehtaShareholding of Promoter and Promoter Group0%0
Subodhbhai Vrajlal ParikhShareholding of Promoter and Promoter Group0%0
Shardaben Subodhbhai ParikhShareholding of Promoter and Promoter Group0%0
Pritesh Subodhbhai ParikhShareholding of Promoter and Promoter Group0%0
Kanakben Arvindbhai ShahShareholding of Promoter and Promoter Group0%0
Yogeshbhai Harilal ShahShareholding of Promoter and Promoter Group0%0
Ketan Harilal ShahShareholding of Promoter and Promoter Group0%0
Nemish Harilal ShahShareholding of Promoter and Promoter Group0%0
Nkm Nextgen LlpShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Nirav Kirtikumar Mehta00%2026-06-30
Kirtikumar Laxmidas Mehta00%2026-06-30
Minaxi Kirtikumar Mehta00%2026-06-30
Ankurbhai K Mehta00%2026-06-30
Dipaben Niravkumar Mehta00%2026-06-30
Brinda Ankur Mehta00%2026-06-30
Hetvi Nirav Mehta00%2026-06-30
Vanshaj Niravkumar Mehta00%2026-06-30
Jitendrakumar Champaklal Vora00%2026-06-30
Chandrika Jitendrakumar Vora00%2026-06-30
Nehal Devang Vora00%2026-06-30
Heti Darshan Kothari00%2026-06-30
Board of Directors
NameDesignationYear
KIRTIKUMAR LAXMIDAS MEHTAChairman(Non Exe)&Dir(Non-Ind)2026
NIRAVKUMAR KIRTIKUMAR MEHTAED / MD / CEO / Promoter2026
ANKUR KIRTIKUMAR MEHTAED / Joint MD / Promoter2026
VIRAL BHUPENDRABHAI SITWALAE D & Wholetime Director2026
Ameet DesaiIndependent Non Exe. Director2026
Monica KanugaIndependent Non Exe. Director2026
Shirish Gundopant BelapureIndependent Non Exe. Director2026
Bhaskar Vemban IyerIndependent Non Exe. Director2026
Chetna DarajiyaCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr
Segments — Geography
RegionRevenueShare
In India₹1,152 Cr96.3%
Outside India₹44 Cr3.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10616161
Corporate Actions
TypeDateValueRemark
dividend2026-06-19₹10.0 (100.0%)Final
dividend2026-06-19₹10 (100%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202605012221
2026000104
202605010218
Company Information
Incorporated2004
ChairmanKIRTIKUMAR LAXMIDAS MEHTA
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
🌐 www.coronaremedies.com

📍 Corona House C-Mondeal Busines, #NAME?, Ahmedabad, Gujarat, 380059

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search